Zepbound

Zepbound is a prescription weight-loss medication developed by Eli Lilly that uses the GLP-1/GIP agonist tirzepatide to help adults with obesity or overweight manage their weight.

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.